After a 36% crash in their value on Tuesday, shares in drugmaker Indivior PLC (LSE:INDV) were on firmer footing in afternoon trading Wednesday.
And, it seems, that at least one leading investment bank is keeping the faith with the group, which specialises in the treatment of addiction and mental illness.
Deutsche Bank has cut its financial forecasts along with its price target for the stock, which drops from 2,350p to 1,500p - which is still almost double the current share price of 756.5p (flat on the day).